Clinical Trial Update: Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study [Phase 2, Phase 3]

View source ↗

Summary

Open-label extension update of a Phase 2/Phase 3 trial evaluating intravitreal Triamcinolone for diabetic macular edema; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Triamcinolone acetonide (intravitreal) (triamcinolone acetonide)

Snippet

Sponsor: University of Sydney | Conditions: Diabetic Macular Oedema | Phase 2, Phase 3 | Status: COMPLETED